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Derek A. Mann⇑
Institute of Cellular Medicine, Newcastle University,
Newcastle upon Tyne, UK⇑Corresponding author. E-mail address: Derek.Mann@ncl.ac.ukTo the Editor:
We note the omission described by Dr. Tsochatzis and colleagues.
We fully agree that the collagen proportionate area (CPA) method
is a valuable tool for quantiﬁcation of ﬁbrotic collagen in diseased
liver and that its correlation with HVPG is an important observa-
tion. However, to our knowledge, CPA has not yet been validated
as a methodology for the assessment of regression of human liver
ﬁbrosis. Critically, the focus of our review was to survey the cur-
rently available data in the published literature that provides evi-
dence for regression of ﬁbrosis across the distinct liver disease
etiologies. Due to this focus and space limitations, we were
unable to undertake a detailed consideration of emerging tech-
nologies that might be applied for detailed analysis of ﬁbrosis
regression, including CPA. We are pleased that Dr. Tsochatzis
has highlighted the likely utility of CPA and look forward to
future work that examines its application in studies of ﬁbrosisJournal of Hepatology 201regression. We thank the Journal of Hepatology for providing a
forum for this interesting discussion.
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Department of Nutrition and Food Hygiene,
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Harbin, ChinaTo the Editor:
We read with great interest the article by Dunn et al., published in
March 2012 [1]. This cross-sectional study reported some inter-
esting observations on the relationship between modest alcohol
consumption and non-alcoholic steatohepatitis (NASH). However,
the study has some limitations.
Dunn et al., clearly demonstrated that modest alcohol con-
sumption was signiﬁcantly inversely associated with NASH,
which was consistent with other recent studies [2,3]. However,
some important confounding factors were not considered or dis-
cussed. First, the rate of diabetes in the lifetime non-drinkers
was signiﬁcantly higher than that of modest drinkers (37.5% vs.
22.1%), but this was not included as a covariant in the multiple
logistic regression analysis. As subjects with diabetes are more
prone to have fatty liver disease, this difference should be consid-
ered in the analysis. Second, soft drinks consumption might also
be an important factor. Early studies have reported that soft
drinks, especially fructose, contribute to the development of dia-
betes and non-alcoholic fatty liver disease (NAFLD) [4]. In addi-
tion, lifetime non-drinkers may drink more soft drinks than
modest drinkers do, which may also affect the result. However,
this confounding factor was not mentioned or discussed in the
article either. Third, as the mechanisms of the inverse association
between alcohol consumption and NAFLD or NASH are still
unclear, genetic factors might be the answer to this question.
Alcohol consumption might interact with some genetic factors
and lead to NAFLD or NASH. We believe the authors have consid-
ered this and investigated several SNPs, ﬁnding that PNPLA3 geno-
type was signiﬁcantly different between the two groups. Again,
this polymorphism was not included in the multiple logistic
regression analysis. Thus, in our opinion, future studies should
consider all the above mentioned factors, which would help inter-
pret their important ﬁndings.2Conﬂict of interest
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